Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Checkpoint Therapeutics Inc (NQ: CKPT )

3.510 +0.070 (+2.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 561,327
Open 3.420
Bid (Size) 3.440 (40)
Ask (Size) 3.590 (5)
Prev. Close 3.440
Today's Range 3.385 - 3.530
52wk Range 1.360 - 3.970
Shares Outstanding 41,631,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024
CKPT stock results show that Checkpoint Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+60.27%
+60.27%
1 Month
+61.01%
+61.01%
3 Month
+59.55%
+59.55%
6 Month
+115.34%
+115.34%
1 Year
+78.17%
+78.17%

More News

Read More
CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)
From The Law Offices of Frank R. Cruz
Via Business Wire
CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
From Faruqi & Faruqi LLP
Via GlobeNewswire
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
From The Rosen Law Firm PA
Via GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
From Faruqi & Faruqi LLP
Via GlobeNewswire
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
CKPT SHAREHOLDER ALERT: TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
From The Rosen Law Firm PA
Via GlobeNewswire
SHAREHOLDER ALERT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
From Faruqi & Faruqi LLP
Via GlobeNewswire
June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today
From Robbins LLP
Via GlobeNewswire
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
From Faruqi & Faruqi LLP
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.